| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.05▼ | 1.05▼ | 1.05▼ | 1.11▼ | 0.97▲ |
| MA10 | 1.07▼ | 1.07▼ | 1.07▼ | 1.07▲ | 0.96▲ |
| MA20 | 1.10▼ | 1.09▼ | 1.11▼ | 0.95▲ | 0.95▲ |
| MA50 | 1.13▼ | 1.11▼ | 1.08▼ | 0.96▲ | 1.08▼ |
| MA100 | 1.14▼ | 1.06▼ | 0.98▲ | 0.94▲ | 1.11▼ |
| MA200 | 1.10▼ | 0.96▲ | 0.96▲ | 1.07▼ | 1.55▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.005▼ | -0.006▼ | -0.011▼ | 0.023▲ | 0.022▲ |
| RSI | 35.964▼ | 40.274▼ | 43.410▼ | 58.550▲ | 53.405▲ |
| STOCH | 6.924▼ | 6.924▼ | 6.808▼ | 65.436 | 40.479 |
| WILL %R | -94.444▼ | -94.444▼ | -95.833▼ | -45.276 | -43.396 |
| CCI | -73.887 | -74.205 | -79.365 | 46.064 | 89.479 |
|
Monday, March 30, 2026 08:39 PM
RenovoRx Inc (RNXT) reports over $1 million in 2025 revenue, outlines ambitious plans to triple its commercial footprint by the end of 2026.
|
|
Monday, March 30, 2026 01:53 PM
RenovoCath® Generates $1.1 Million in 2025 Revenue in First Full Year of Commercialization Phase III TIGeR-PaC Trial on Track for Enrollment Completion by the Middle of 2026, and Final Data ...
|
|
Thursday, March 26, 2026 06:14 AM
TIGeR-PaC Trial Enrollment Remains on Track for Completion in First Half of 2026, with Final Data Expected in 2027 Select TIGeR-PaC Cancer Centers Now Using RenovoCath® as a Stand-Alone Device for ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 30/03/26 | 1.13 | 1.13 | 1.01 | 1.07 | 333,575 |
| 27/03/26 | 1.15 | 1.17 | 1.06 | 1.13 | 522,830 |
| 26/03/26 | 1.10 | 1.30 | 1.10 | 1.16 | 1,453,370 |
| 25/03/26 | 1.08 | 1.14 | 1.0601 | 1.10 | 397,775 |
| 24/03/26 | 1.11 | 1.19 | 1.05 | 1.08 | 627,022 |
| 23/03/26 | 0.99 | 1.13 | 0.98 | 1.11 | 584,887 |
| 20/03/26 | 1.03 | 1.03 | 0.9701 | 1.00 | 264,657 |
| 19/03/26 | 1.02 | 1.05 | 0.9701 | 1.01 | 475,720 |
| 18/03/26 | 1.01 | 1.08 | 0.9775 | 1.03 | 805,028 |
| 17/03/26 | 0.9889 | 1.05 | 0.96 | 0.9663 | 539,065 |
|
|
||||
|
|
||||
|
|